// App-Quantinova.ai

3005 : The impact of mitochondrially targeted oncology agents on mitochondrial DNA (mtDNA) integrity

Researchers

Presenter

  • Kaytee L. Pokrzywinski

Principal Investigators

  • Thomas G. Biel

  • Dmitry Kryndushkin

  • V. Ashutosh Rao

Medical Centers

  • U.S. Food and Drug Administration, Silver Spring, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • MitoQ

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved